In vehicle-controlled comparisons, Captopril lowered blood pressure and improved endothelium-dependent relaxation of mesenteric resistance arteries in CTR, but not dKO mice. In UM‐HET3 mice, Captopril mixed with chow increased median lifespan by 6% in females and 13% in males when data were pooled across sites. In spontaneously hypertensive rats, Captopril administered in drinking water returned final SBP to normal values, reaching 138 ± 0.8 mm Hg. [1,2,3]
Captopril lowered blood pressure in CTR, but not dKO mice
Animal study · CTR mice [1]
CTR or dKO mice were administered captopril (10 mg/kg body weight) or vehicle via intraperitoneal injection per day for 4 weeks. Captopril lowered blood pressure and improved endothelium-dependent relaxation of mesenteric resistance arteries from CTR, but not dKO mice.
Conditions shared by the study groups
- Route
- intraperitoneal injection
- Treatment course
- per day for 4 weeks
- Captopril 10 mg/kg body weight
- Model: CTR mice
- Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Captopril
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Endothelial Sp1 and Sp3 are implicated in the effects of captopril (S75); Methods > Animals (S164, S165, S168); Fig. 6 legend (S379)
SBP and MBP: SBP and MBP; comparator: vehicle — Results > Endothelial Sp1 and Sp3 are implicated in the effects of captopril (S75); Methods > Animals (S168); Fig. 6 legend (S379)
Captopril 10 mg/kg body weight · Results > Endothelial Sp1 and Sp3 are implicated in the effects of captopril (S75); Methods > Animals (S168)
Captopril increases median lifespan in mice
Animal study · UM‐HET3 mice [2]
UM‐HET3 mice received Captopril at 180 ppm mixed with chow beginning at 5 months of age, with chow without additives as the control. In data pooled across all sites, median lifespan increased in females by 6% (p = 0.002) and in males by 13% (p = 0.001).
Conditions shared by the study groups
- Route
- mixed with chow
- Treatment course
- fed to mice beginning at 5 months of age
- Vehicle
- Purina 5LG6
- Captopril 180 ppm
- Model: UM‐HET3 mice
Methods and source locations
Compound reported in the paper: Captopril
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
RESULTS > Standard analysis (S10, S20); EXPERIMENTAL PROCEDURES > Animals (S65, S71); EXPERIMENTAL PROCEDURES > Control and experimental diets (S90, S91)
median lifespan: median lifespan; comparator: Purina 5LG6 without additives — RESULTS > Standard analysis (S20)
Captopril 180 ppm · RESULTS > Standard analysis (S20); EXPERIMENTAL PROCEDURES > Control and experimental diets (S91)
Captopril restores systolic blood pressure in hypertensive rats
Animal study · spontaneously hypertensive rats (SHR) aged 18-20 weeks; six animals each [3]
Spontaneously hypertensive rats received Captopril at 80 mg/kg/day in drinking water for 12 weeks, with untreated rats as controls. Final SBP returned to normal values, at 138 ± 0.8 mm Hg.
Conditions shared by the study groups
- Route
- dissolved in the drinking water
- Treatment course
- during 12 weeks
- Vehicle
- drinking water
- Captopril 80 mg/kg/day
- Model: spontaneously hypertensive rats (SHR) aged 18-20 weeks; six animals each
Methods and source locations
Compound reported in the paper: Captopril
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Methods > Animals, treatments, heart tissue sampling and measurements in plasma (S2, S5, S6); Results > Body weight, left ventricle weight, blood pressure and heart rate (S55); Table 1 (T1.h1, T1.r4)
Final SBP (mm Hg): Final SBP (mm Hg); comparator: SHR (untreated) — Results > Body weight, left ventricle weight, blood pressure and heart rate (S55); Table 1 (T1.h1, T1.r4)
Captopril 80 mg/kg/day · Methods > Animals, treatments, heart tissue sampling and measurements in plasma (S6); Results > Body weight, left ventricle weight, blood pressure and heart rate (S55); Table 1 (T1.h1, T1.r4)